PET/MRI in cancer patients: first experiences and vision from Copenhagen
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
PET/MRI in cancer patients : first experiences and vision from Copenhagen. / Kjær, Andreas; Loft, Annika; Law, Ian; Berthelsen, Anne Kiil; Borgwardt, Lise; Löfgren, Johan; Johnbeck, Camilla Bardram; Hansen, Adam Espe; Keller, Sune; Holm, Søren; Højgaard, Liselotte.
In: Magnetic Resonance Materials in Physics, Biology and Medicine, 2013.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - PET/MRI in cancer patients
T2 - first experiences and vision from Copenhagen
AU - Kjær, Andreas
AU - Loft, Annika
AU - Law, Ian
AU - Berthelsen, Anne Kiil
AU - Borgwardt, Lise
AU - Löfgren, Johan
AU - Johnbeck, Camilla Bardram
AU - Hansen, Adam Espe
AU - Keller, Sune
AU - Holm, Søren
AU - Højgaard, Liselotte
PY - 2013
Y1 - 2013
N2 - Combined PET/MRI systems are now commercially available and are expected to change the medical imaging field by providing combined anato-metabolic image information. We believe this will be of particular relevance in imaging of cancer patients. At the Department of Clinical Physiology, Nuclear Medicine & PET at Rigshospitalet in Copenhagen we installed an integrated PET/MRI in December 2011. Here, we describe our first clinical PET/MR cases and discuss some of the areas within oncology where we envision promising future application of integrated PET/MR imaging in clinical routine. Cases described include brain tumors, pediatric oncology as well as lung, abdominal and pelvic cancer. In general the cases show that PET/MRI performs well in all these types of cancer when compared to PET/CT. However, future large-scale clinical studies are needed to establish when to use PET/MRI. We envision that PET/MRI in oncology will prove to become a valuable addition to PET/CT in diagnosing, tailoring and monitoring cancer therapy in selected patient populations.
AB - Combined PET/MRI systems are now commercially available and are expected to change the medical imaging field by providing combined anato-metabolic image information. We believe this will be of particular relevance in imaging of cancer patients. At the Department of Clinical Physiology, Nuclear Medicine & PET at Rigshospitalet in Copenhagen we installed an integrated PET/MRI in December 2011. Here, we describe our first clinical PET/MR cases and discuss some of the areas within oncology where we envision promising future application of integrated PET/MR imaging in clinical routine. Cases described include brain tumors, pediatric oncology as well as lung, abdominal and pelvic cancer. In general the cases show that PET/MRI performs well in all these types of cancer when compared to PET/CT. However, future large-scale clinical studies are needed to establish when to use PET/MRI. We envision that PET/MRI in oncology will prove to become a valuable addition to PET/CT in diagnosing, tailoring and monitoring cancer therapy in selected patient populations.
U2 - http://dx.doi.org/10.1007/s10334-012-0357-0
DO - http://dx.doi.org/10.1007/s10334-012-0357-0
M3 - Journal article
JO - Magnetic Resonance Materials in Physics, Biology, and Medicine
JF - Magnetic Resonance Materials in Physics, Biology, and Medicine
SN - 0968-5243
ER -
ID: 48459230